FRM
CELL

Fox Run Management’s PhenomeX Inc. Common Stock CELL Stock Holding History

Fox Run Management’s Portfolio CELL Stock Details CELL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-15,155
Closed -$296K – 753
2021
Q3 		$296K Buy
+15,155
New +$576K 0.19% 238

Other funds holding CELL

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
SUT
SC US (TTGP) Menlo Park, California $9.25B AUM 20.49% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Fox Run Management's CELL Position: Q4 2021 in Review

Fox Run Management sold out of PhenomeX Inc. Common Stock (CELL) in Q4 2021, closing a stake of 15,155 shares — an estimated $296K sold.

Fox Run Management first reported a position in CELL in Q3 2021 and held it in 1 quarter. The position peaked at $296K in Q3 2021. 132 funds tracked by Wall St. Rank hold CELL as of Q4 2021.

  • Fox Run Management reported no remaining PhenomeX Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Fox Run Management sold 15,155 PhenomeX Inc. Common Stock shares in Q4 2021, an estimated $296K.
  • Fox Run Management first reported a position in PhenomeX Inc. Common Stock in Q3 2021 and held it in 1 quarter.
  • Fox Run Management's PhenomeX Inc. Common Stock position peaked at $296K in Q3 2021.
  • 132 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q4 2021.

Based on Fox Run Management's 13F filing for Q4 2021, filed 9 Feb 2022.